This video demonstrates a wide-excision prostatectomy for patients with locally advanced, high-risk prostate cancer.
Section Editor’s note: ‘Y’tube, a new video section of UrologyTimes.com, is a resource for urologists and other clinicians who focus on men’s health. ‘Y’tube covers surgical aspects of a variety of men’s health issues with the ultimate goal of accumulating a library of videos to serve as a reference.
This video demonstrates a wide-excision prostatectomy for patients with locally advanced, high-risk prostate cancer. Special emphasis is placed on early incision into Denonvillier's fascia and close dissection along the longitudinal muscle fibers of the rectum. An extended lymph node dissection is performed and emphasis is also placed on widely excising posterior lateral tissue as well as the bladder neck to help minimize positive margins in this very high-risk cohort.
The video demonstrates a bilateral wide-excision technique, but can be performed unilaterally should nerve sparing be possible on the contralateral side.
Dr. Hotaling: The techniques demonstrated in this video by Dr. Dechet-and also in a video by William J. Ellis, MD-are adaptations of classical open surgical radical retropubic prostatectomy by surgeons who were trained before robot-assisted laparoscopic prostatectomy (RALP) became widely available. The techniques shown by these two-high volume surgeons with excellent outcomes add to the armamentarium of the robotic prostate surgeon.
Subscribe to Urology Times to get monthly news from the leading news sources for urologists.
Targeted radiation plus systemic therapy combo shows promise in mHSPC
March 18th 2024"The combination of highly potent systemic therapy and targeted radiation has shown impressive results in maintaining low PSA levels after testosterone recovery, offering hope for improved outcomes in these patients, but further studies are still needed to determine the best regimen," says Amar U. Kishan, MD.
Relugolix plus radiotherapy shows safety, efficacy in prostate cancer
March 14th 2024“Remarkably, relugolix demonstrated a faster return to baseline testosterone levels compared [with] traditional therapies, a crucial aspect for patients' quality of life post-treatment," says Daniel E. Spratt, MD.